within Pharmacolibrary.Drugs.ATC.J;

model J01DB07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.08333333333333333,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Cefatrizine is a first-generation cephalosporin antibiotic that was developed for the treatment of a variety of bacterial infections, primarily respiratory and urinary tract infections. It is administered orally. Cefatrizine is not currently approved for use in many countries and has limited clinical use today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for oral administration in healthy adult subjects, based on data available for similar cephalosporins as no primary literature directly reporting cefatrizine PK parameters was identified.</p><h4>References</h4><ol><li><p>Pfeffer, M, et al., &amp; Ximenez, J (1983). Human intravenous pharmacokinetics and absolute oral bioavailability of cefatrizine. <i>Antimicrobial agents and chemotherapy</i> 24(6) 915–920. DOI:<a href=&quot;https://doi.org/10.1128/AAC.24.6.915&quot;>10.1128/AAC.24.6.915</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6660858/&quot;>https://pubmed.ncbi.nlm.nih.gov/6660858</a></p></li><li><p>Papantoniou, N, et al., &amp; Antsaklis, A (2007). Pharmacokinetics of oral cefatrizine in pregnant and non-pregnant women with reference to fetal distribution. <i>Fetal diagnosis and therapy</i> 22(2) 100–106. DOI:<a href=&quot;https://doi.org/10.1159/000097105&quot;>10.1159/000097105</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17135753/&quot;>https://pubmed.ncbi.nlm.nih.gov/17135753</a></p></li><li><p>Verhaegen, J, &amp; Verbist, L (1992). Oral cephalosporins. <i>Acta clinica Belgica</i> 47(6) 377–386. DOI:<a href=&quot;https://doi.org/10.1080/17843286.1992.11718259&quot;>10.1080/17843286.1992.11718259</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1337810/&quot;>https://pubmed.ncbi.nlm.nih.gov/1337810</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01DB07;
